BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10421247)

  • 1. Adherence to guidelines for antiretroviral therapy and for preventing opportunistic infections in HIV-infected adults and adolescents in Ryan White-funded facilities in the United States.
    Kaplan JE; Parham DL; Soto-Torres L; van Dyck K; Greaves JA; Rauch K; Ellis B; Amandus HE
    J Acquir Immune Defic Syndr; 1999 Jul; 21(3):228-35. PubMed ID: 10421247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.
    Jones JL; Hanson DL; Dworkin MS; Alderton DL; Fleming PL; Kaplan JE; Ward J
    MMWR CDC Surveill Summ; 1999 Apr; 48(2):1-22. PubMed ID: 12412613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis for opportunistic infections among HIV-infected patients receiving medical care.
    Sackoff J; McFarland J; Su S; Bryan E
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):387-92. PubMed ID: 9833748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint effects of HIV-1 RNA levels and CD4 lymphocyte cells on the risk of specific opportunistic infections.
    Williams PL; Currier JS; Swindells S
    AIDS; 1999 Jun; 13(9):1035-44. PubMed ID: 10397533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
    Mofenson LM; Brady MT; Danner SP; Dominguez KL; Hazra R; Handelsman E; Havens P; Nesheim S; Read JS; Serchuck L; Van Dyke R; ; ; ; ;
    MMWR Recomm Rep; 2009 Sep; 58(RR-11):1-166. PubMed ID: 19730409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Underuse of primary Mycobacterium avium complex and Pneumocystis carinii prophylaxis in the United States.
    Asch SM; Gifford AL; Bozzette SA; Turner B; Mathews WC; Kuromiya K; Cunningham W; Andersen R; Shapiro M; Rastegar A; McCutchan JA
    J Acquir Immune Defic Syndr; 2001 Dec; 28(4):340-4. PubMed ID: 11707670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on opportunistic infections.
    Proj Inf Perspect; 1997 Nov; (23):16-7. PubMed ID: 11365373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.
    Masur H; Kaplan JE; Holmes KK; ;
    Ann Intern Med; 2002 Sep; 137(5 Pt 2):435-78. PubMed ID: 12617574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.
    Kaplan JE; Masur H; Holmes KK; ;
    MMWR Recomm Rep; 2002 Jun; 51(RR-8):1-52. PubMed ID: 12081007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-effectiveness of preventing AIDS-related opportunistic infections.
    Freedberg KA; Scharfstein JA; Seage GR; Losina E; Weinstein MC; Craven DE; Paltiel AD
    JAMA; 1998 Jan; 279(2):130-6. PubMed ID: 9440663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stopping preventive treatments.
    Fornataro K; Jefferys R
    Body Posit; 1999 Jul; 12(7):9-10. PubMed ID: 11367080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group.
    McNaghten AD; Hanson DL; Jones JL; Dworkin MS; Ward JW
    AIDS; 1999 Sep; 13(13):1687-95. PubMed ID: 10509570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to guidelines for the prevention of HIV-related respiratory diseases.
    Montaner JS; Phillips P; Zala C; Craib KJ; O'Shaughnessy MV; Schechter MT
    Eur Respir J; 1996 Nov; 9(11):2318-22. PubMed ID: 8947078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumonia in HIV-infected patients in the HAART era: incidence, risk, and impact of the pneumococcal vaccination.
    López-Palomo C; Martín-Zamorano M; Benítez E; Fernández-Gutiérrez C; Guerrero F; Rodríguez-Iglesias M; Girón-González JA
    J Med Virol; 2004 Apr; 72(4):517-24. PubMed ID: 14981752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is primary mycobacterium avium complex prophylaxis necessary in patients with CD4 <50 cells/μL who are virologically suppressed on cART?
    Yangco BG; Buchacz K; Baker R; Palella FJ; Armon C; Brooks JT;
    AIDS Patient Care STDS; 2014 Jun; 28(6):280-3. PubMed ID: 24833016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.
    Kaplan JE; Benson C; Holmes KK; Brooks JT; Pau A; Masur H; ; ;
    MMWR Recomm Rep; 2009 Apr; 58(RR-4):1-207; quiz CE1-4. PubMed ID: 19357635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.
    Currier JS; Williams PL; Koletar SL; Cohn SE; Murphy RL; Heald AE; Hafner R; Bassily EL; Lederman HM; Knirsch C; Benson CA; Valdez H; Aberg JA; McCutchan JA
    Ann Intern Med; 2000 Oct; 133(7):493-503. PubMed ID: 11015162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OI prophylaxis in antiretroviral responders: stay the course or bite the bullet?
    Currier JS
    AIDS Clin Care; 1998 Oct; 10(10):73-5, 79-80. PubMed ID: 11365859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High rates of primary Mycobacterium avium complex and Pneumocystis jiroveci prophylaxis in the United States.
    Gebo KA; Fleishman JA; Reilly ED; Moore RD;
    Med Care; 2005 Sep; 43(9 Suppl):III23-30. PubMed ID: 16116306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of care for HIV infection provided by Ryan White Program-supported versus Non-Ryan White Program-supported facilities.
    Sullivan PS; Denniston M; Mokotoff E; Buskin S; Broyles S; McNaghten AD
    PLoS One; 2008 Sep; 3(9):e3250. PubMed ID: 18806878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.